23andMe is ending its cancer research program and slashing over 200 jobs
Source: The Verge 23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s massive data breach and reverse its plummeting stock price. The genetic testing company also announced that it will shut down its therapeutics business. Though 23andMe says the restructuring plan will…